CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $37,000 | -65.7% | 18,424 | -53.6% | 0.00% | – |
| Q4 2021 | $108,000 | +21.3% | 39,686 | +98.1% | 0.00% | -100.0% |
| Q3 2021 | $89,000 | -18.3% | 20,036 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $109,000 | +31.3% | 18,811 | +59.4% | 0.00% | -66.7% |
| Q1 2021 | $83,000 | +33.9% | 11,802 | -9.0% | 0.00% | +50.0% |
| Q4 2020 | $62,000 | -17.3% | 12,976 | +0.4% | 0.00% | -33.3% |
| Q3 2020 | $75,000 | -3.8% | 12,918 | +12.1% | 0.00% | -25.0% |
| Q2 2020 | $78,000 | -76.4% | 11,522 | +58.2% | 0.00% | -50.0% |
| Q2 2018 | $331,000 | +6.8% | 7,283 | +23.9% | 0.01% | 0.0% |
| Q1 2018 | $310,000 | -23.8% | 5,877 | -1.7% | 0.01% | -27.3% |
| Q4 2017 | $407,000 | -11.5% | 5,981 | +7.1% | 0.01% | -21.4% |
| Q3 2017 | $460,000 | +2.2% | 5,587 | +16.1% | 0.01% | -6.7% |
| Q2 2017 | $450,000 | +62.5% | 4,811 | +10.4% | 0.02% | +7.1% |
| Q1 2017 | $277,000 | +3.4% | 4,357 | +49.5% | 0.01% | -50.0% |
| Q3 2015 | $268,000 | +18.6% | 2,915 | +13.3% | 0.03% | +27.3% |
| Q2 2015 | $226,000 | – | 2,573 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |